Total Payments
$1,330
2024 Payments
$39.07
Companies
13
Transactions
60
Medicare Patients
919
Medicare Billing
$103,839
Payment Breakdown by Category
Food & Beverage$1,124 (84.5%)
Education$205.93 (15.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,124 | 56 | 84.5% |
| Education | $205.93 | 4 | 15.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $383.51 | 13 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $171.48 | 14 | $0 (2019) |
| Janssen Biotech, Inc. | $130.31 | 7 | $0 (2022) |
| Alkermes, Inc. | $124.99 | 1 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $117.48 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $115.32 | 7 | $0 (2019) |
| Allergan Inc. | $99.97 | 6 | $0 (2019) |
| Melinta Therapeutics, LLC | $65.08 | 4 | $0 (2021) |
| ViiV Healthcare Company | $44.72 | 2 | $0 (2023) |
| ABBVIE INC. | $25.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.07 | 2 | ABBVIE INC. ($25.82) |
| 2023 | $44.72 | 2 | ViiV Healthcare Company ($44.72) |
| 2022 | $36.59 | 2 | Janssen Biotech, Inc. ($36.59) |
| 2021 | $254.42 | 3 | Alkermes, Inc. ($124.99) |
| 2019 | $173.53 | 10 | Gilead Sciences, Inc. ($56.96) |
| 2018 | $223.34 | 14 | Astellas Pharma US Inc ($56.59) |
| 2017 | $558.01 | 27 | Astellas Pharma US Inc ($310.23) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/20/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: HIV | ||||||
| 06/21/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: HIV | ||||||
| 05/23/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/03/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/17/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: CNS | ||||||
| 10/12/2021 | Melinta Therapeutics, LLC | Vabomere (Drug) | Education | In-kind items and services | $11.95 | General |
| Category: ANTIBIOTICS | ||||||
| 08/18/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $117.48 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.26 | General |
| 09/25/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/24/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DELSTRIGO | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/03/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/07/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.54 | General |
| 05/01/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ANTIBIOTICS | ||||||
| 04/17/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/27/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/23/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ANTIBIOTICS | ||||||
| 01/17/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.16 | General |
| 12/19/2018 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 12/06/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2018 | Melinta Therapeutics, Inc. | Vabomere (Drug), Orbactiv, MINOCIN | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/26/2018 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 244 | 412 | $69,849 | $26,745 |
| 2022 | 5 | 233 | 359 | $74,970 | $26,047 |
| 2021 | 5 | 189 | 287 | $56,020 | $19,882 |
| 2020 | 5 | 253 | 442 | $85,250 | $31,165 |
Total Patients
919
Total Services
1,500
Medicare Billing
$103,839
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 133 | $22,280 | $7,810 | 35.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 51 | $19,209 | $6,505 | 33.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 63 | 153 | $11,658 | $5,761 | 49.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 38 | $9,738 | $3,780 | 38.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 19 | $4,170 | $1,548 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 18 | $2,794 | $1,341 | 48.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 75 | 153 | $30,600 | $8,164 | 26.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 44 | $14,300 | $6,710 | 46.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 43 | 77 | $17,325 | $5,913 | 34.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 39 | 41 | $9,225 | $4,044 | 43.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 34 | 44 | $3,520 | $1,217 | 34.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 57 | 123 | $24,600 | $6,714 | 27.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 38 | 38 | $12,350 | $5,717 | 46.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 36 | $8,100 | $3,606 | 44.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 26 | $5,850 | $2,016 | 34.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 38 | 64 | $5,120 | $1,829 | 35.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 85 | 211 | $42,200 | $11,984 | 28.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 62 | 63 | $20,475 | $9,833 | 48.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 38 | 39 | $8,775 | $4,218 | 48.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 54 | 105 | $8,400 | $3,176 | 37.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 24 | $5,400 | $1,955 | 36.2% |
About Dr. Cynthia Wong, MD
Dr. Cynthia Wong, MD is a Internal Medicine healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891751418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cynthia Wong, MD has received a total of $1,330 in payments from pharmaceutical and medical device companies, with $39.07 received in 2024. These payments were reported across 60 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,124).
As a Medicare-enrolled provider, Wong has provided services to 919 Medicare beneficiaries, totaling 1,500 services with total Medicare billing of $103,839. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Syracuse, NY
- Active Since 04/22/2006
- Last Updated 01/22/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891751418
Products in Payments
- LYBALVI (Drug) $124.99
- IMBRUVICA (Drug) $117.48
- Cresemba (Drug) $116.25
- AVYCAZ (Drug) $83.75
- ISENTRESS (Drug) $79.34
- CRESEMBA (Drug) $73.28
- Vabomere (Drug) $65.08
- PREZCOBIX (Drug) $48.86
- Symtuza (Drug) $44.86
- CABENUVA (Biological) $44.72
- NOXAFIL (Drug) $42.82
- TEFLARO (Drug) $42.04
- SYMTUZA (Drug) $36.59
- ZERBAXA (Drug) $26.23
- STIOLTO RESPIMAT (Drug) $14.21
- CUBICIN RF (Drug) $13.32
- Arikayce (Drug) $13.25
- BREO (Drug) $12.02
- TRELEGY ELLIPTA (Drug) $11.52
- DIFICID (Drug) $9.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Syracuse
Dr. Stephen Thomas, Md, MD
Internal Medicine — Payments: $265,661
Internal Medicine $265,661
Ambika Eranki
Internal Medicine — Payments: $35,555
Internal Medicine $35,555
Yola Augustin, Md, MD
Internal Medicine — Payments: $15,654
Internal Medicine $15,654
Shashank Bhatt, M.d, M.D
Internal Medicine — Payments: $8,877
Internal Medicine $8,877
Namita Chittoria
Internal Medicine — Payments: $8,817
Internal Medicine $8,817
Michael Kuhn, Md, MD
Internal Medicine — Payments: $8,740
Internal Medicine $8,740